KIR3DL1 and myeloid sarcoma: Secondly, the decision to include the KIR genes in the analysis is supported by recent publications suggesting that NK cell-mediated immunity may actively regulate MS evolution through different combinations of KIR/HLA haplotypes (Kaur et al., 2013; Bettencourt et al., 2014; Shahsavar et al., 2016; Karimizadeh et al., 2020).